399 related articles for article (PubMed ID: 28376292)
1. Hepatitis B virus sequencing and liver fibrosis evaluation in HIV/HBV co-infected Nigerians.
Grant J; Agbaji O; Kramvis A; Yousif M; Auwal M; Penugonda S; Ugoagwu P; Murphy R; Hawkins C
Trop Med Int Health; 2017 Jun; 22(6):744-754. PubMed ID: 28376292
[TBL] [Abstract][Full Text] [Related]
2. Association between hepatitis B co-infection and elevated liver stiffness among HIV-infected adults in Lusaka, Zambia.
Vinikoor MJ; Mulenga L; Siyunda A; Musukuma K; Chilengi R; Moore CB; Chi BH; Davies MA; Egger M; Wandeler G;
Trop Med Int Health; 2016 Nov; 21(11):1435-1441. PubMed ID: 27499385
[TBL] [Abstract][Full Text] [Related]
3. Impact of Antiretroviral Therapy on Liver Fibrosis Among Human Immunodeficiency Virus-Infected Adults With and Without HBV Coinfection in Zambia.
Vinikoor MJ; Sinkala E; Chilengi R; Mulenga LB; Chi BH; Zyambo Z; Hoffmann CJ; Saag MS; Davies MA; Egger M; Wandeler G;
Clin Infect Dis; 2017 May; 64(10):1343-1349. PubMed ID: 28158504
[TBL] [Abstract][Full Text] [Related]
4. Analysis of HBV basal core promoter/precore gene variability in patients with HBV drug resistance and HIV co-infection in Northwest Ethiopia.
Belyhun Y; Liebert UG; Maier M
PLoS One; 2018; 13(2):e0191970. PubMed ID: 29408943
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B virus genotype G: prevalence and impact in patients co-infected with human immunodeficiency virus.
Dao DY; Balko J; Attar N; Neak E; Yuan HJ; Lee WM; Jain MK
J Med Virol; 2011 Sep; 83(9):1551-8. PubMed ID: 21739445
[TBL] [Abstract][Full Text] [Related]
6. [Analysis of the relationship between hepatitis B virus precore and basal core promoter mutations and acute-on-chronic liver failure].
Ma XY; Han T; Pei YZ; Zhao ZG; Gao YT; Li Y; Jing L
Zhonghua Gan Zang Bing Za Zhi; 2012 Sep; 20(9):644-8. PubMed ID: 23207226
[TBL] [Abstract][Full Text] [Related]
7. Precore G1896A mutation is associated with reduced rates of HBsAg seroclearance in treated HIV hepatitis B virus co-infected patients from Western Africa.
Boyd A; Moh R; Maylin S; Abdou Chekaraou M; Mahjoub N; Gabillard D; Anglaret X; Eholié SP; Delaugerre C; Danel C; Zoulim F; Lacombe K;
J Viral Hepat; 2018 Oct; 25(10):1121-1131. PubMed ID: 29660214
[TBL] [Abstract][Full Text] [Related]
8. Liver function test abnormalities in Nigerian patients with human immunodeficiency virus and hepatitis B virus co-infection.
Iroezindu MO; Agbaji OO; Daniyam CA; Isiguzo GC; Isichei C; Akanbi MO
Int J STD AIDS; 2013 Jun; 24(6):461-7. PubMed ID: 23970749
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus basal core promoter/precore mutants and association with liver cirrhosis in children with chronic hepatitis B virus infection.
Zhong YW; Di FL; Liu C; Zhang XC; Bi JF; Li YL; Wu SQ; Dong H; Liu LM; He J; Shi YM; Zhang HF; Zhang M
Clin Microbiol Infect; 2016 Apr; 22(4):379.e1-379.e8. PubMed ID: 26577140
[TBL] [Abstract][Full Text] [Related]
10. Different precore/core mutations of hepatitis B interact with, limit, or favor liver fibrosis severity.
Ducancelle A; Pivert A; Bertrais S; Boursier J; Balan V; Veillon P; le Guillou-Guillemette H; Thibault V; Castelain S; Roquebert B; Coste-Burel M; Mackiewicz V; Schvoerer E; Larrat S; Maylin S; Alain S; Loustaud-Ratti V; Gordien E; Gozlan J; Brodard V; Chevaliez S; Calès P; Lunel-Fabiani F
J Gastroenterol Hepatol; 2016 Oct; 31(10):1750-1756. PubMed ID: 26992056
[TBL] [Abstract][Full Text] [Related]
11. Changes in liver stiffness after ART initiation in HIV-infected Nigerian adults with and without chronic HBV.
Grant JL; Agaba P; Ugoagwu P; Muazu A; Okpokwu J; Akpa S; Machenry S; Imade G; Agbaji O; Thio CL; Murphy R; Hawkins C
J Antimicrob Chemother; 2019 Jul; 74(7):2003-2008. PubMed ID: 31225612
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of hepatocarcinoma-related hepatitis B virus mutants in patients in grey zone of treatment.
Gil-García AI; Madejón A; Francisco-Recuero I; López-López A; Villafranca E; Romero M; García A; Olveira A; Mena R; Larrubia JR; García-Samaniego J
World J Gastroenterol; 2019 Oct; 25(38):5883-5896. PubMed ID: 31636479
[TBL] [Abstract][Full Text] [Related]
13. Precore/core promoter mutations and hepatitis B virus genotype in hepatitis B and C dually infected patients treated with interferon-based therapy.
Hung CH; Chen CH; Lu SN; Wang JH; Hu TH; Huang CM; Tsai MC; Lee CM
Antiviral Res; 2012 Jan; 93(1):55-63. PubMed ID: 22061616
[TBL] [Abstract][Full Text] [Related]
14. HBV and HIV viral load but not microbial translocation or immune activation are associated with liver fibrosis among patients in South Africa.
Maponga TG; Andersson MI; van Rensburg CJ; Arends JE; Taljaard J; Preiser W; Glashoff RH
BMC Infect Dis; 2018 May; 18(1):214. PubMed ID: 29739341
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B virus genotype B with G1896A and A1762T/G1764A mutations is associated with hepatitis B related acute-on-chronic liver failure.
Xiao L; Zhou B; Gao H; Ma S; Yang G; Xu M; Abbott WG; Chen J; Sun J; Wang Z; Hou J
J Med Virol; 2011 Sep; 83(9):1544-50. PubMed ID: 21739444
[TBL] [Abstract][Full Text] [Related]
16. BCP/PC mutation prevalence and their association with HBV replication in HIV/HBV co-infected patients.
Li D; Chen Q; Tao C
Arch Virol; 2018 Oct; 163(10):2829-2833. PubMed ID: 29948380
[TBL] [Abstract][Full Text] [Related]
17. Impact of hepatitis B virus infection on human immunodeficiency virus response to antiretroviral therapy in Nigeria.
Idoko J; Meloni S; Muazu M; Nimzing L; Badung B; Hawkins C; Sankalé JL; Ekong E; Murphy R; Kanki P; Thio CL
Clin Infect Dis; 2009 Oct; 49(8):1268-73. PubMed ID: 19772386
[TBL] [Abstract][Full Text] [Related]
18. Genotyping and virological characteristics of hepatitis B virus in HIV-infected individuals in Sudan.
Yousif M; Mudawi H; Hussein W; Mukhtar M; Nemeri O; Glebe D; Kramvis A
Int J Infect Dis; 2014 Dec; 29():125-32. PubMed ID: 25449246
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus genotype and basal core promoter/precore mutations are associated with hepatitis B-related acute-on-chronic liver failure without pre-existing liver cirrhosis.
Ren X; Xu Z; Liu Y; Li X; Bai S; Ding N; Zhong Y; Wang L; Mao P; Zoulim F; Xu D
J Viral Hepat; 2010 Dec; 17(12):887-95. PubMed ID: 20070500
[TBL] [Abstract][Full Text] [Related]
20. Mutations in basal core promoter is associated with significant fibrosis in both HBeAg positive and negative treatment-naïve chronic hepatitis B.
Yan LB; Zhu X; Bai L; Tang XQ; Du LY; Chen EQ; Liang LB; Tang H
Clin Res Hepatol Gastroenterol; 2017 Jun; 41(3):296-302. PubMed ID: 27988305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
